G protein-coupled receptors (GPCRs) are major drug targets and have high potential for drug discovery. The development of a method for measuring the activities of GPCRs is essential for pharmacology and drug screening. However, it is difficult to measure the effects of a drug by monitoring the receptor on the cell surface, and changes in the concentrations of downstream signaling molecules, which depend on signaling pathway selectivity of the receptor, are used as an index of the receptor activity. Here, we show that single-molecule imaging analysis provides an alternative method for assessing ligand effects on GPCR. We monitored the dynamics of the diffusion of metabotropic glutamate receptor 3 (mGluR3), a class C GPCR, under various ligand conditions by using total internal reflection fluorescence microscopy (TIRFM). The single-molecule tracking analysis demonstrates that changes in the average diffusion coefficient of mGluR3 quantitatively reflect the ligand-dependent activity. Then, we reveal that the diffusion of receptor molecules is altered by the common physiological events associated with GPCRs, including G protein binding or accumulation in clathrin-coated pits, by inhibition experiments and dual-color singlemolecule imaging analysis. We also confirm the generality of agonist-induced diffusion change in class A and B GPCRs, demonstrating that the diffusion coefficient is a good index for estimating the ligand effects on many GPCRs regardless of the phylogenetic groups, chemical properties of the ligands, and G protein-coupling selectivity.
Introduction
G protein-coupled receptors (GPCRs) constitute the largest superfamily of human membrane proteins, and are classified into several families based on their sequence similarity (1, 2) . About 33% of all small-molecule drugs target just 6% of the ~800 human GPCRs (3, 4) ; thus, GPCRs have immense potential for drug discovery. However, it is difficult to measure the effects of a drug by monitoring the receptor on the cell surface, and changes in the concentrations of downstream signaling molecules, including second messengers, are monitored as an index of the receptor activity (5) . These conventional methods require background knowledge about the signaling pathways, including coupling specificity to G protein subtypes. Here, we developed an alternative method for assessing ligand effects on GPCRs by monitoring the movements of receptor molecules on living cells under a microscope.
Total internal reflection fluorescence microscopy (TIRFM) is a common imaging method for observing single molecules on the bottom plasma membrane of a living cell (6) (7) (8) . Dimerization and diffusion of the M1 muscarinic receptor (9) and the N-formylpeptide receptor (10) have been measured by TIRFM, but there was limited information about the activation process because the fluorescent dyes were conjugated with agonists in these studies, preventing observation of the inactive state. Recent studies have reported that the oligomerization and diffusion of the adrenergic receptors (11, 12) , GABA B receptors (11) , and dopamine D 2 receptors (13) change upon ligand stimulation; however, the physiological background and generality of these observations are unknown.
Here, we examined the relationship between the diffusion and functional states of metabotropic glutamate receptor 3 (mGluR3) as a model class C GPCR. Class C GPCRs have a large extracellular ligand-binding domain (ECD) on the N-terminal side of the seven alpha-helical transmembrane domains (TMDs) (Fig. 1A ). The ECDs function as an obligatory dimer, where dimeric reorientation occurs upon ligand binding (14, 15) . The conformational change in ECDs promotes the dimeric rearrangement of TMDs (16) (17) (18) , activating a protomer of the TMD dimer (19, 20) . Single-molecule tracking (SMT) analysis demonstrated that the average diffusion coefficient (D Av ) of mGluR3 quantitatively reflects receptor activity. The inhibition experiments and dualcolor TIRFM analysis indicated that the slowing of mGluR3 was related to the decoupling of the receptor/G protein coupling complex followed by the receptors accumulating in clathrin-coated pits (CCPs). We verified the generality of the agonistinduced change in the diffusion dynamics of GPCRs by comparing the D Av of nine GPCRs in various phylogenetic positions.
Results

Expression, fluorescence labeling, single-molecule imaging of HaloTag fusion mGluR3
To determine the relationship between the diffusion coefficient and activity of mGluR3, we monitored the single-molecule movement of tetramethylrhodamine (TMR)-labeled HaloTag fusion mGluR3 on HEK293 cells under various ligand conditions ( Fig. 1, Movie 1) . The fusion of HaloTag to the C-terminus of mGluR3 did not alter the dimerization, ligand binding, and G protein activation (Fig. S1 ).
In previous studies, N-terminally SNAP-tagged GPCRs were labeled with nonmembrane-permeable fluorophores (11) (12) (13) . In this method, only the receptor molecules on the cell surface are labeled at a certain time point, similar to a pulse-chase experiment. Therefore, exocytosis and endocytosis of the receptor molecules after labeling alter the composition of visible receptor molecules on the cell surface depending on the incubation time. Especially, agonist-induced internalization of the receptors causes selective loss of the activated receptors. In contrast, we used membrane-permeable fluorophores, which allow uniform labeling of the receptor molecules in a cell. Whole-cell labeling is important for monitoring the total number of receptor molecules, with and without ligand, on the cell surface, including newly exocytosed receptors after labeling.
When using membrane-permeable fluorophores, non-specific binding of the fluorophores in the cell should be evaluated carefully. We used the HaloTag TMR ligand (TMR), HaloTag STELLA Fluor 650 ligand (SF650), and SNAP-Cell 647-SiR ligand (SiR) to label GPCRs or G proteins. TMR showed the least non-specific binding in mock transfected cells ( Fig. S2A-F ). It was difficult to use more than 300 nM SF650 or SiR for single-molecule imaging because of the high amount of non-specific binding ( Fig. S2D-F) . We also evaluated the specific binding affinity of fluorophores to Halo/SNAP-tagged proteins based on the difference in fluorescence intensity between the tagged protein-expressing and non-expressing cells ( Fig. S2A-C) . The affinity to the HaloTag was fourfold higher for SF650 than for TMR. In terms of photostability and brightness, SF650 also performed better than TMR under our experimental conditions ( Fig. S2G and H, Materials and Methods). However, TMR achieved a higher rate of dye labeling under low non-specific binding conditions.
In the single-molecule imaging of mGluR3, ~95% of the HaloTag-fused mGluR3 molecules were specifically labeled with 300 nM TMR, according to the saturation binding assay using the HaloTag TMR ligand (Fig. S2A , Materials and Methods). Because HEK293 cells express no detectable mRNA for mGluRs (21) , almost all receptor molecules were labeled in the present measurements. The mean density of receptor molecules on a cell surface was 0.40 ± 0.11 particles/μm 2 in the singlemolecule images ( Fig. S2I ; mean ± SD).
Time-dependent mean square displacement (MSD-Δt) analysis of HaloTag fusion mGluR3
MSD-Δt plot analysis is often used to evaluate the diffusion coefficient and diffusion mode of membrane proteins (7, 9, 11, 13) . The MSD corresponds to the average squared distance that a receptor molecule travels from its starting point within a certain time interval Δt, which is proportional to the apparent lateral diffusion coefficient. A linear MSD-Δt plot is observed when the receptor molecules exhibit simple Brownian diffusion (22) . On the other hand, a concave-up or -down shape of the MSD-Δt plot suggests that the receptor molecules exhibit directed or confined diffusion modes, respectively (22) .
We quantified the MSD from the trajectories traced by SMT in each cell (Fig.  1B) , and analyzed the dose-dependent change in the total average MSDs of the trajectories (Fig. 1C-E) . Stimulation with the inverse agonist LY341495 significantly increased the MSD of mGluR3 molecules (Fig. 1C ). In contrast, stimulation with the agonist LY379268 significantly decreased the MSD in a dose-dependent manner (Fig.  1D ). We also analyzed the LY379268-dependent diffusion change of mGluR3 in the presence of 1 μM MNI137, a negative allosteric modulator (NAM) (23) . MNI137 binding to the TMD suppressed the agonist-dependent decrease of MSD, and no significant difference was observed upon LY379268 stimulation ( Fig. 1E ).
Relationship among average diffusion coefficient, ligand binding affinity, and G protein activation efficiency of mGluR3
We calculated the D Av of mGluR3 molecules from the MSD (equations 1 and 2 in Methods). The dose-dependent curves showed the LY341495-induced increase and LY379268-induced decrease of D Av in the absence of other ligands (Fig. 1F ). The LY379268-dependent decrease of D Av was greater in the presence of 100 nM LY341495, and was significantly suppressed by the addition of 1 μM MNI137 ( Fig.  1G ). To compare the dose-dependency of D Av with the ligand-binding affinity of mGluR3, we performed an in vitro [ 3 H]-LY341495 binding assay ( Fig. 1H , I). The EC 50 value of the LY341495-induced increase of D Av (Fig. 1F ) was at most half that of [ 3 H]-LY341495 binding (Fig. 1H ). The IC 50 values of the LY379268-induced decrease of D Av without and with 100 nM LY341495 ( Fig. 1F , G) were at most twice that of the competition binding curve between LY379268 and 100 nM [ 3 H]-LY341495 ( Fig. 1H) . These results suggested that the dose-dependency of D Av corresponded well with the ligand-binding affinity. The effect of MNI137 on mGluR3 could not be measured by the [ 3 H]-LY341495 binding assay; no significant difference was observed with and without 1 μM MNI137 ( Fig. 1I ).
We also measured the G protein activation efficiencies of mGluR3 under the same ligand conditions with an in vitro [ 35 S]-GTPγS binding assay. mGluR3 showed a high G protein activation even without ligands, and this basal activity was suppressed by LY341495 in a concentration-dependent manner (Fig. 1J ). This is consistent with a recent study demonstrating that Clbinding to the ECD causes high basal activity of mGluR3 (24, 25) . Thus, the inverse agonist-induced increase and agonist-induced decrease of D Av in Fig. 2A reflected the change in the equilibrium between the inactive and active states of mGluR3 molecules on the cell surface. Furthermore, 1 μM MNI137 significantly suppressed the agonist-induced increase of G protein activation efficiency ( Fig. 1K ), as expected from D Av of mGluR3 (Fig. 1G ). The IC 50 of LY341495-induced suppression of the basal activity ( Fig. 1J ) was one order of magnitude smaller than those obtained from the ligand-binding assay ( Fig. 1H ) and from the dose-dependency of D Av (Fig. 1F ). Furthermore, there was a difference of two orders of magnitude between the EC 50 values of the LY379268-dependent increase of G protein activation efficiencies with ( Fig. 1K ) and without 100 nM LY341495 ( Fig.  1J) , where that with 100 nM LY341495 was similar to those estimated from the ligand binding assay ( Fig. 1H ) and from the dose-dependency of D Av (Fig. 1F , G). Generally, it is difficult to estimate the ligand occupancy from a downstream response after amplification of the signaling cascade because the response is usually saturated at a ligand concentration lower than the saturation binding (26) . Single-molecule imaging analysis allows us to assess the fraction of receptors in the inactive and active states, which corresponds well to the fraction of ligand binding.
Ligand-induced changes in the mGluR3 diffusion state distribution
Next, we performed variational Bayesian-hidden Markov model (VB-HMM) clustering analysis (27, 28) to classify the diffusion states of mGluR3. VB-HMM analysis of the total trajectories suggested that the diffusion of mGluR3 molecules could be classified into four states (immobile, slow, medium, fast) ( Figs. 2A, B , S3, and Movie 1). The fast and medium states contained transient directional and nondirectional movements and their MSD-Δt plots were linear in the average (Fig. S3C, D) . In contrast, concave-down MSD-Δt plots were observed in the slow and immobile states ( Fig. S3E , F), indicating the confined diffusion of mGluR3 (22) . The confinement lengths were estimated to be 140 and 70 nm, respectively ( Fig. S3E , F, and Methods), which were consistent with the radii of plasma membrane microdomains (29) . The distribution of the apparent oligomer size of mGluR3 in each diffusion state was estimated from the intensity histogram based on the sum of Gaussian functions. The mean intensity of monomeric TMR estimated from the intensity histogram of TMRlabeled CD86, a monomeric membrane protein, on HEK293 cells (11) ( Fig. S3G ), was about half of that of the highest peak in the histogram of mGluR, suggesting that the majority of mGluR forms dimers (Fig. S3H ). The higher-order clusters of mGluR3 were mainly related to the immobile state, where the intensity histogram was right-shifted compared with the other diffusion states (Fig. S3H ).
Upon LY341495 stimulation, the fraction of fast state molecules significantly increased, whereas the fractions of immobile and slow state molecules decreased in a dose-dependent manner (Fig. 2C ). In contrast, LY379268 stimulation increased the fraction of the immobile and slow states, but decreased the fraction of the fast state ( Fig.  2D ). To analyze the transitions among the four states, we estimated the time constants of the state transition from the VB-HMM transition array ( Figs. 2E, S4 ). The dosedependent changes were mainly observed in the transition from the slower to the faster states, suggesting that the activation of mGluR3 made it difficult to escape from the microdomain and that mGluR3 was trapped in a slower state. The diffusion coefficients of medium and slow states estimated from the VB-HMM analysis also changed significantly upon ligand stimulation (Figs. 2E, S5). The ligand-induced changes in D Av in Fig. 1F , G, were derived from the opposite change in the fraction of the fast state compared with the slow and immobile states, and also from the changes in the diffusion coefficients in the medium and slow states ( Fig. 2E ).
Effects of pertussis toxin on mGluR3 molecule diffusion
We analyzed the effect of pertussis toxin (PTX), an inhibitor of G i/o proteins, to link the diffusion state with the G protein-bound state of mGluR3 (Fig. 3A) . The PTX treatment decreased the average diffusion coefficient significantly ( indicating that the ADP-ribosylation of the G i/o α-subunit by the A protomer was responsible for the slowing of mGluR3. These results suggest that the fast diffusion state contained G i/o protein-bound mGluR3 for both the inactive and active ligand conditions. This is consistent with previous studies, which demonstrated precoupling of GPCRs with G protein even in the inactive state, enabling fast signal transduction (31) (32) (33) (34) . The activation of mGluR3 triggered a release of G i/o from the precoupling complex, similar to PTX-induced decoupling (Fig. 3A) , thereby decreasing the fast state fraction. Thus, the decrease in D Av upon agonist stimulation in Fig. 1F , G is partly explained by the decrease in mGluR3 coupling with G i/o protein.
Dual-color TIRFM analysis of mGluR3 and G o protein colocalization
To observe the interaction between mGluR3 and G protein directly, we performed dual-color single-molecule imaging analysis. We detected colocalization of TMRtagged mGluR3 and SiR-tagged G o protein on HEK293 cell membranes in the presence of 1 μM LY341495 (inactive) or 100 μM LY379268 (active) with or without PTX treatment. The rate of SiR dye labeling of G o protein was estimated as ~12% ( Fig. S2C ).
We observed mGluR3 molecules colocalizing with G o proteins both under the inactive and active ligand conditions ( Fig. 4A , B, Movie 2). Binding of G o protein occasionally accelerated mGluR3 diffusion (Movie 2). PTX treatment significantly decreased the MSD of mGluR3 in the presence of exogenous G o protein at saturating ligand concentrations ( Fig. 4C , D). The ligand conditions did not affect the probability of mGluR3 and G o protein colocalization; however, PTX treatment significantly decreased it ( Fig. 4E ). These decreases were caused mainly by the decreased on-rate between mGluR3 and G o proteins, because no significant difference was observed in the cumulative histogram of colocalization duration ( Fig. 4F ). We compared the diffusion state fraction of mGluR3 colocalized with G o protein (mGluR3/G o ) with that of mGluR3 colocalized with total mGluR3 (mGluR3/total) in the presence or absence of PTX. Under all conditions, the fractions of the fast and medium states were significantly higher for mGluR3/G o than for mGluR3/total ( Fig. 4G, H) . Taken together, the PTXinduced deceleration of mGluR3 movement is explained mainly by inhibited formation of the mGluR3/G protein complexes that diffuse faster.
Dual-color TIRFM analysis of mGluR3 colocalized with clathrin
We investigated the physiological events related to the immobile and slow states that increased upon activation of mGluR3, in contrast to the decrease in the fast state. A TIRFM image showed that the immobile state was related to clustering of mGluR3 molecules followed by internalization ( Fig. 5A ). Immobile clusters of mGluR3 were formed and disappeared with rapid directional movement (Movie 3). To test whether the clusters were receptors in the CCP, we analyzed the colocalization of TMR-labeled mGluR3 and green fluorescent protein (GFP)-labeled clathrin light chain (CLC) by dual-color TIRFM. When mGluR3 and CLC were colocalized, TMR intensity increased rapidly ( Fig. 5B , C, and Movie 4). The intensities of TMR and GFP decreased simultaneously several seconds after colocalization ( Fig. 5C ). These results suggested that mGluR3 formed a large cluster in a CCP and the cluster was internalized as a clathrin-coated vesicle in the cytoplasmic region, which could not be reached by the evanescent light ( Fig. 5A ).
Next, we quantified the distribution of the diffusion states of mGluR3 colocalized with CLC (mGluR3/CLC) and compared it with the total number of mGluR3 molecules (mGluR3/total) for the inactive (100 nM LY341495) and active (100 μM LY379268) ligand conditions. The immobile and slow state fractions were significantly higher in mGluR3/CLC than in mGluR3/total, indicating that the clathrin binding immobilized the receptor (blue and red lines, Fig. 5D ). Comparing the inactive and active ligand conditions demonstrated that the fraction of the immobile state of mGluR3/CLC increased upon activation (black lines, Fig. 5D ). Furthermore, the probability and time constant of the colocalization between mGluR3 and CLC were increased significantly after activation ( Fig. 5E -G). The cumulative histogram of the colocalization duration was fitted with a double exponential function with short and long time constants (Fig.  5F ). The time constants were ~1.5 times greater for the active than the inactive ligand condition ( Fig. 5G ), indicating that the ~1.8-fold increase in the probability of colocalization observed in Fig. 5E was caused mainly by the increased duration of colocalization. Thus, the immobile state fraction in the total trajectories reflected the number of mGluR3 molecules interacting with clathrin molecules, which increased upon activation.
Effects of RNA interference (RNAi)-mediated CLC inhibition on mGluR3 molecule diffusion
To distinguish between mGluR3 activation and internalization, we measured the effects of RNAi-mediated CLC knockdown on mGluR3 diffusion. Western blotting analysis indicated that transfection of siRNAs specific to CLC reduced the level of CLC by ~50% in HEK293 cells ( Fig. 6A ). Knockdown of CLC significantly increased the average MSD of mGluR3 under the basal (vehicle) and active (100 μM LY379268) ligand conditions ( Fig. 6B , D), reflecting decreases in the slow and immobile states and an increase in the fast state ( Fig. 6E, G) . In contrast, no significant changes were observed under the inactive (1 μM LY341495) ligand condition ( Fig. 6C, F) . These results suggested that RNAi of CLC decreased the slowly diffusing mGluR3-clathrin complex and increased the fast state fraction including mGluR3-G protein complex.
Correlation between receptor density, mean oligomer size, and D Av
We also analyzed the ligand-induced changes in mean oligomer size, which should be related to internalization. However, the mean oligomer size showed no clear dose-dependency ( Fig. S6A-C ). This may be due to the higher correlation between mean oligomer size and receptor density ( Fig. S6D-G) . The mean oligomer size of mGluR3 was significantly and positively correlated with receptor density (Fig. S6G ). Thus, the strict selection of cells based on receptor density is required to test the ligand effect on oligomer size. In contrast, no significant correlation was observed between receptor density and D Av (Fig. S7) . D Av is a robust index of mGluR3 activity that is independent of the receptor expression level.
Generality of the agonist-induced diffusion change of GPCRs
To test the generality of the relationship between the diffusion and activation of GPCRs, we monitored the single-molecule movement of fluorescently labeled GPCRs in other classes (Table 1, Movie 5). Because it is not necessary to label all the molecules in a cell to measure D Av , we used 30 nM SF650 for labeling to improve the quality of the single-molecule imaging. Under the labeling conditions, ~70% of receptors were labeled with SF650 with lower non-specific binding ( Fig. S2B ).
We compared the MSD-Δt plots of the trajectories of GPCR molecules with and without agonist stimulation (Fig. S8) , and calculated D Av as listed in Table 1 . All the GPCRs tested showed significant slowing upon agonist stimulation regardless of the phylogenetic positions, chemical properties of the ligands, and G protein-coupling selectivity ( Table 1 , Fig. S8 ). In the absence of ligands, mGluR3 showed lower D Av (0.047 μm 2 /s) than other GPCRs (0.06-0.09 μm 2 /s), which corresponded to that of mGluR3 with 1 μM LY341495 (0.064 μm 2 /s) (Table 1) . Thus, the diffusion coefficient of mGluR3 was similar to those of other GPCRs in the inactive state ( Fig. 2E ). In the presence of an agonist, the D Av of GPCRs was 0.04-0.07 μm 2 /s. A drug effect on each GPCR was accurately detected by SMT analysis as a change in D Av (Table 1) , but the absolute values of D Av varied between GPCRs.
Discussion
The present study provides a new method for assessing the effects of drugs on GPCRs by monitoring the diffusion behavior of GPCRs. We first obtained proof-ofconcept of the applicability of single-molecule imaging to the pharmacology of a class C GPCR, mGluR3. The basal activity, agonist-induced activation, inverse agonistinduced inactivation, and NAM-dependent suppression of activity can be evaluated by measuring D Av of mGluR3 on the living cell surface (Fig. 1) . The dose-dependent change of D Av was derived from the population shift of the four diffusion states and the change of the diffusion coefficient of each state ( Fig. 2E ). The plasma membrane is partitioned into submicrometer-scale domains with different lipid compositions, including lipid rafts (35) . Assuming that the four diffusion states are determined primarily by the lipid environment of receptor molecules, ligand-induced conformational changes followed by interactions with other molecules would alter the accessibility of the receptor to membrane domains. A previous single-molecule imaging study also suggested that the lateral diffusion of transmembrane proteins is transiently anchored by the actin cytoskeleton, which impedes diffusion across the membrane domains freely (36) . Furthermore, CCPs on the plasma membrane restrict the receptors to confined areas (37) . The present study suggested that the agonist and inverse agonist stimulations increased and decreased, respectively, the distribution of mGluR3 molecules within these microdomains, which was partly related to the binding partner of mGluR3, such as G protein and clathrin ( Fig. 7) .
The PTX treatment assay suggested that the fast state is related to the mGluR3 binding with the G protein ( Fig. 3, 4 ). Before the experiment, we expected that PTX would have an effect only under the active ligand conditions; however, this was not the case. The slowing of the mGluR3 by PTX was observed more clearly under the inactive ligand conditions ( Fig. 3, 4 ), providing evidence of mGluR3/G protein precoupling. Furthermore, we directly observed transient formation of the mGluR3/G protein complex under both the inactive and active ligand conditions ( Fig. 4A , B, and Movie 2). PTX treatment inhibited formation of the mGluR3/G o complex, which diffuses faster than the average mGluR3 molecule ( Fig. 4E , G, H). Although the fraction of fluorescent G o -coupled mGluR3 molecules was small (~0.4% of the total mGluR molecules), at least ~3.3% of mGluR3 molecules were colocalized with G o , considering the dye labeling rate of G o (~12%) and photobleaching of fluorophores during the measurements. Taking into account the endogenous G i proteins, whose precise concentrations were unknown, the actual fraction of the mGluR3/G i/o protein complex was higher. Thus, the twofold reduction of the mGluR3/G i/o protein complex by PTX treatment seen in Fig. 4E would reasonably explain the ~4% change in the diffusion state distribution of total mGluR3 molecules in Figs. 3 and 4.
Precoupling with G proteins has been demonstrated for class A GPCRs such as adrenergic and muscarinic acetylcholine receptors. The ternary complex model, which assumes that receptor/G protein precoupling induces the high-affinity state of GPCRs, was proposed before the discovery of G proteins (38) , and it is widely accepted to depict the properties of agonist/GPCR associations. Although there was no evidence of high-affinity state formation of mGluRs, a previous study using nanodiscs demonstrated that a single TMD of mGluR2, which cannot bind glutamate, can couple with G proteins (39) . However, the basal activity of GPCRs, including mGluR3, made it difficult to distinguish the receptor/G protein precoupling complex from spontaneously activated receptor binding to G proteins using biochemical methods. Studies using Förster resonance energy transfer and fluorescence recovery after photobleaching confirmed the presence of precoupling complexes of the α 2A adrenergic receptor, muscarinic M3 and M4 receptors, adenosine A1 receptor, and protease-activated receptor 1 under the inactive ligand conditions (31) (32) (33) (34) . In the present study, we could not distinguish the precoupling complex from the active complex by colocalization probability or duration ( Fig. 4E, F ). From the view point of diffusion, the active complex showed a trend toward becoming immobile compared with the precoupling complex ( Fig. 4G, H) . This is consistent with a recent dual-color TIRFM analysis of adrenergic receptors and G proteins suggesting that the active receptor/G protein complex is formed in a confined region of the plasma membrane (12) . The difference in mobility between precoupling and active complexes may be an additional reason for the increase in the mGluR3 immobile fraction upon activation.
Currently, it is unknown why G protein binding sometimes accelerates the diffusion of mGluR3 ( Fig. 4G and Movie2), even though simple physical models predict slower diffusion of particles of larger volume (40) . We speculate that the major determinant of the diffusion coefficient of mGluR3 is the viscosity of the membrane surrounding the receptor molecule, which is dependent on the lipid composition. G protein binding would increase the accessibility of mGluR3 to a less viscous membrane environment. In addition, a previous report revealed that crossing the diffusion barrier was controlled by the interaction between the C-terminal region of mGluR5 and a cytosolic partner in astrocytes (41) . Receptor/G protein precoupling, in which the Cterminal region of the GPCR also plays an essential role (33) , would affect the ability to cross the membrane microdomain for a similar reason.
The recruitment of GPCRs into CCPs is a well-established mechanism for endocytosis regardless of the GPCR family. The dual-color TIRFM analysis demonstrated that the immobile state of mGluR3 is related to the interaction with clathrin molecules (Fig. 5 ). During desensitization, GPCRs are phosphorylated by G protein-coupled receptor kinases, followed by the recruitment of arrestins (42) . Then, the GPCR/arrestin complexes are gathered into CCPs through the interactions between arrestin, clathrin, and the AP2 adaptor (42) . Previously, the clathrin-mediated endocytosis of class A GPCRs, including adrenergic and opioid receptors, was analyzed by TIRFM under high-expression conditions where a single receptor molecule could not be resolved, and it was demonstrated that the GPCR cargo regulates the surface residence time of CCPs (43, 44) . The present results indicate that the time constant of colocalization between mGluR3 and CLC molecules increases upon agonist stimulation ( Fig. 5F, G) , which is qualitatively consistent with these previous reports. The absolute values of the colocalization time constant were two orders of magnitude shorter than the previously reported values for bulk imaging, and is probably due to the higher photobleaching rate of single TMR ligands (~3 s) in single-molecule imaging. Thus, it is rare to observe the whole process, from the recruitment of receptors into the CCP to the internalization, as shown in Fig. 5B , C, where the clustering rate of the receptorclathrin complex was greater than the photobleaching rate. RNAi-mediated knockdown of CLC also suggested that the mGluR3 interacting with clathrin was in the slow and immobile state. These results are consistent with a single-molecule imaging analysis of neurokinin-1 receptor, a class A GPCR (37) .
These physiological events, which affect diffusion, are not specific to class C GPCRs. If a drug effect on a GPCR can be estimated from a common change in the diffusion dynamics, we could perform drug assessments of GPCRs without knowing the specific signaling cascade. Therefore, we verified the generality of the diffusion change upon activation in various GPCRs in other classes. Comparison of the diffusion coefficients of GPCRs with and without an agonist demonstrated that the slowing of receptor diffusion upon activation is a general feature of GPCRs irrespective of the signaling pathways downstream of the receptor (Table 1, Fig. S8 ).
The agonist-induced increases of diffusion coefficients of GABA B (11) and dopamine D 2 receptors (13) were reported in previous studies. The apparent discrepancy between the present study and previous studies was attributed to the labeling method used in each study as described above. Furthermore, there is a clear difference between the analysis in the present study and that used in the study by Tabor et al., (13) who excluded slow-moving receptors (D < 0.02 μm 2 /s). If we performed a similar analysis here, the immobile and slow diffusion fractions of mGluR3 would be almost completely filtered out, resulting in a misleading evaluation of D Av .
In conclusion, the diffusion coefficient is a good index for estimating the drug effects on various GPCRs on a living cell. The present method can be applied to HEK293 cells transiently expressing fluorescently labeled GPCRs because D Av is hardly affected by variability in the cell surface receptor density (Fig. S7 ). On the other hand, the mean oligomer size was positively correlated with the receptor density on cell surface (Fig. S6 ). Further comprehensive dual-color TIRFM analyses are required to assess the broad generality of the state-dependent dimerization or oligomerization of GPCRs in the future.
Because it is possible to quantify the diffusion of any GPCR by using TIRFM, our technique could be useful for drug screening of many GPCRs, including orphan GPCRs, about which little is known. We anticipate that the present study will contribute to the future development of a single-molecule dynamics-based pharmacological method for GPCRs.
Materials and Methods
Materials
[ 3 H]-LY341495 (1.28 TBq/mmol), LY341495, LY379268, NMI137, and NECA, serotonin were purchased from Tocris Cookson. Isoproterenol, histamine, DHA, CXCL12, TRAP-6, and glucagon were purchased from Santa Cruz, Wako, Sigma Aldrich, Thermo Fisher, BACHEM, and CEDARLANE, respectively. [ 35 S]-GTPγS (37 TBq/mmol) was purchased from PerkinElmer Life Sciences. PTX and B oligomer were purchased from Wako Chemicals. Human CD86 cDNA was purchased from OriGene. siRNAs targeting CLCs (5′-GACUUUAACCCCAAGUCUAGC-3′ and 5′-UAGACUUGGGGUUAAAGUCAC-3′ for CLTA; 5′-GGCUUAAAGGGUGUGUUGUUG-3′ and 5′-ACAACACACCCUUUAAGCCAA-3′ for CLTB) were designed and purchased from RNAi Inc. The anti-CLC monoclonal antibody (C1985) and anti-β-actin monoclonal antibody (A5441) were purchased from Sigma.
Construction of cDNA
The HaloTag7 (Promega) coding sequence was amplified by PCR, and was fused at the C-terminus of mouse mGluR3 with an In-Fusion HD Cloning Kit (Clontech). To quantify the expression of wild type and HaloTag-fused mGluR3 by Western blotting analysis, the epitope sequence of the anti-bovine rhodopsin monoclonal antibody Rho1D4 was also fused at the C-terminus. The cDNAs of mGluR3s were introduced into the pcDNA3.1 mammalian expression vector (Invitrogen). The cDNAs of other GPCRs (ADRB2, HTR2A, HRH1, ADORA2A, FFAR4, CXCR4, F2R, GCGR) were purchased from Promega, and the receptor coding sequences were inserted into pFC14K HaloTag CMV Flexi Vector. The CD86 (M1-R277) coding sequence was amplified by PCR, and inserted into the pEGFP-N1 mammalian expression vector (Clontech), where the coding sequence of EGFP was swapped with that of HaloTag7. The SNAP-tag (NEB) coding sequence was amplified by PCR and inserted in the loop region between L91 and G92 of the mouse Gα o subunit coding cDNA, as reported previously (12) . The SNAP-tagged Gα o subunit coding sequence was inserted into the pFC15A HaloTag CMVd1 Flexi Vector without the HaloTag coding sequence to reduce the expression level for single-molecule imaging. The cDNA of GFP-tagged CLC was constructed as previously reported (45) .
Single-molecule imaging
HEK293 cells were cultured in DMEM/F12 containing phenol red (Gibco) supplemented with 15 mM HEPES (pH 7.3), 29 mM NaHCO 3 , and 10% FBS at 37 °C under 5% CO 2 . The plasmid DNA of HaloTag-fused mGluR3 was transfected into HEK293 cells cultured on glass coverslips (Matsunami) on a 60-mm dish 1 day before imaging. Lipofectamine 3000 (Invitrogen) was used for transfection. After 15 min incubation at room temperature, the transfection mixture (plasmid DNA (0.1 μg), P3000 reagent (0.2 μL), Lipofectamine 3000 reagent (2.5 μL), and Opti-MEM (120 μL, Gibco)) was added to cells cultured with DMEM/F12 (3 mL) on a 60-mm dish. For dual-color imaging, the plasmid DNA of GFP-fused CLC (0.02 μg) or SNAP-tag-fused G o protein (0.5 µg) was co-transfected with HaloTag-fused mGluR3. After 3 h incubation at 37 °C under 5% CO 2 , the medium was changed to DMEM/F12 without phenol red (3 mL, Gibco) supplemented with 10% FBS. For the RNAi experiment, siRNAs specific to CLTA and CLTB (36 pmol) were transfected using Lipofectamine RNAiMax (6 μL) the day before transfection of mGluR3 cDNA.
After overnight incubation, the HaloTag-fused mGluR3 was labeled with 300 nM HaloTag TMR ligand (Promega) in DMEM/F12 without phenol red for 15 min at 37 °C under 5% CO 2 . For dual-color labeling of mGluR3 and G o protein, 100 nM SNAP-Cell 647-SiR (NEB) was also added at the same time. For imaging of other GPCRs, we used 30 nM SF650 HaloTag ligand (GORYO Chemical). The HaloTag ligand-treated HEK293 cells on coverslips were washed three times with DMEM/F12 without phenol red (3 mL) in a 60-mm dish. For the inhibitor assay, the cells were treated with 5 nM PTX, 5 nM B oligomer, or vehicle for 6 h at 37 °C under 5% CO 2 before imaging. Cells were washed twice with PBS and DMEM/F12 without FBS before HaloTag ligand treatment.
The coverslip was mounted on a metal chamber (Invitrogen), and washed five times with Hanks' balanced salt solution (HBSS; 400 μL, Sigma); with 15 mM HEPES (pH 7.3) and 0.01% BSA, without NaHCO 3 ). Ligand (5× concentration) or vehicle solution (100 μL) was added to the chamber with 0.01% BSA/HBSS (400 μL) 10 min before imaging. Single-molecule imaging was performed 10-30 min after ligand (or vehicle) stimulation at room temperature (25 °C). The fluorescently-labeled GPCRs on the basal cell membrane were observed with total internal reflection illumination by using an inverted fluorescence microscope (TE2000, Nikon). The cells were illuminated using a 559 nm, 50 mW laser (WS-0559-050, NTT Electronic) or a 532 nm, 100 mW laser (Compass 315M-100) with an ND50 filter for TMR, with a 488 nm, 30% output power of 200 mW laser (Sapphire 488-200, Coherent) for GFP, or with a 637 nm, 140 mW laser (OBIS 637, Coherent) for SiR and SF650 through the objective (PlanApo 60×, NA 1.49, Nikon) by a dichroic mirror (FF493/574, Semrock) for TMR and GFP, (ET Cy3/Cy5, Chroma) for TMR and SiR, or by a single-band filter set (ET Cy5, Chroma) for SF650. The emission light from TMR and GFP/SiR was split into two light paths by a two-channel imaging system (M202J, Nikon) with a dichroic mirror (59004b, Chroma for TMR and GFP, or FF640-FDi01, Semrock for TMR and SiR) and simultaneously detected by two EM-CCD cameras (ImagEM, Hamamatsu) after passing through band-pass filters (ET525/50m and ET605/70m, Chroma for GFP and TMR, or FF01-585/40 and FF01-676/29 for TMR and SiR). The 4× relay lens was placed before the two-channel imaging system to magnify the image (67 nm/pixel). The fluorescence images were recorded with image software (ImagEM HDR, Hamamatsu or MetaMorph, Molecular Devices) with the following settings: exposure time, 30.5 ms for single-color or 33 ms for dual-color imaging; electron multiplying gain, 200; spot noise reduction, on. The cells were fixed to evaluate the accuracies of the positions of TMR-labeled mGluR3, SiR-labeled G o and GFP-labeled CLC was performed according to a previous method (46) . The cells on a coverslip were treated with 4% paraformaldehyde/0.2% glutaraldehyde in PBS for 30 min at room temperature, and they were washed five times with HBSS before imaging.
Analysis of single-molecule images
The multiple TIFF files (16 bit) were processed by ImageJ as follows. Background subtraction was performed with a rolling ball radius of 25 pixels, and twoframe averaging of the images was then conducted by the Running_ZProjector plugin (Vale Lab homepage, http://valelab.ucsf.edu/~nstuurman/ijplugins/). The dual-color images were aligned by the GridAligner plugin (Vale Lab homepage) based on an affine transform algorithm. The two channels were calibrated with scattering images of gold particles (60 nm) recorded on the same day. To keep the single-molecule intensity constant across the images, the display range of the brightness and contrast was set as a constant range (minimum: 0, maximum: 1800) followed by image conversion to avi format (8 bit) without compression. SMT analysis was performed with G-count software (G-angstrom) based on a two-dimensional Gaussian fitting algorithm with the following parameters: region of interest size, 6 pixels; Fluorescence limit, 12 arbitrary units; loop, seven times; minimum of 15 frames.
The calculation of the parameters from trajectories, the curve fittings, and the illustrations in the Figures were obtained with Igor Pro 6.36 (WaveMetrix) as follows.
The MSD within time nΔt of each trajectory was calculated by (22) 
where n is the length of frames, Δt is the frame rate (30.5 ms), and N is the total frame number of the trajectory. D Av was calculated based on the two-dimensional diffusion equation
where MSDj is the MSD of the j-th trajectory and M is the total number of trajectories. D Av in the present study was calculated for n = 6 (n∆t = 183 ms). The EC 50 and IC 50 of the ligand-dependent changes of D Av were calculated by equations 3 and 4, respectively.
The MSD-Δt plot was fitted by (47) 
where L is the confinement length and D is the diffusion coefficient taking the limit of Δt to 0. 
The histogram of the intensity distribution was fitted by sum of the N Gaussian
where n is the oligomer size, and I and σ are mean and SD of a single TMR molecule, respectively. N was determined by using the Akaike information criterion. I and σ were estimated to be 530 and 210 from the measurement of TMR-labeled CD86. The percentage of each oligomer size, Percent(n), and mean oligomer size on each cell surface were calculated by equations 8 and 9, respectively.
Colocalization between TMR-labeled mGluR3 and SiR-labeled G o protein or GFP-labeled CLC was defined as a distance of less than 100 nm between different proteins in the same frame that are in the same diffusion state, estimated by VB-HMM analysis as described below. It is difficult to distinguish between random colocalization and a true interaction based solely on the distance between two molecules within an image, and the analysis program without the criterion of the proteins being in the same diffusion state defined an interaction as a fast-moving G o protein passing an immobile mGluR3 molecule. It is expected that two molecules are in the same diffusion state if they are truly coupled and moving together. In the VB-HMM analysis of mGluR3, G o protein, and CLC, the single-frame displacement histograms were similarly divided into four diffusion states, whereas the fraction of each state was different depending on the protein (Fig. S9) .
The position accuracies of TMR-labeled mGluR3, SiR-labeled G o , and GFPlabeled CLC on the fixed cells were estimated to be 28, 24, and 31 nm, respectively, from 1 SD of the displacement distribution of the immobile particles. The error of the alignment between the two channels after the image processing was estimated to be 18 from the difference in the positions of the same gold particles. Therefore, 100 nm corresponded to ~2 SD of the total position accuracy. The time constants of colocalization were estimated from a curve fitting of the cumulative histogram (Figs. 4F and 5F) by the double exponential equation 8.
The fraction of two components was estimated from the ratio of A 1 to A 2 .
VB-HMM clustering analysis
The VB-HMM analysis was performed with a LabView-based homemade program developed according to previously reported algorithms (27, 28) . A trajectory of mGluR3 molecule consists of time series of step displacements. Each time series of the observed data is given as X = {x 1 , ... , x N }, where N is the total number of frames. A corresponding time series of diffusion states is defined as Z = {z 1 , ... , z N }. Here, z n = {z n1 , ... , z nK }, in which K is the total number of states, and z nk =1 and 0 otherwise for a molecule in the k-th state and n-th frame. In order to estimate the state series Z from the data X, we applied the HMM where Z is assumed to obey the Markov process with transition matrix A. The distributions of the initial state and transition probability are described as follows, respectively: 
where I is the number of parameters. Thus, L q can be written as,
To optimize the distribution functions q(Z) and q(θ), the variational Bayesian (VB)-EM algorithm was applied (49). The VB-E step and VB-M step maximize L q against q(Z) and q(θ), respectively. The VB-E step corresponds to the calculation of ( ) 
, , , , , 
can be factorized to separate terms for each parameter. By optimizing q(θ j ), the expectations of parameters are obtained and used as updated values in the next VB-E step.
The Dirichlet distribution was used for given prior functions of the initial state, transition probability distributions, and the calculated posterior functions. Thus, the log of expectation of the initial state is obtained as ( ) (14)), the prior function, including the diffusion coefficient (D k ), is given by a gamma distribution, and the log-expectation of
where a D and b D are the hyper parameters and assigned values to maximize the lower bound L q , which was rewritten from equation (18) 
where c n is the scaling factor calculated in the VB-E step. The iteration between the VBE-and VBM-step is performed until the lower bound converges.
The VB-HMM analysis on the obtained data was carried out using the following procedure: 1) We set the number of states (N) and divided the data into N groups by the K-means clustering method in which initial values were given by the K means++ method; 2) We calculated the initial parameters of the observation probability for each group; 3) We used the VB-E step to optimize q(Z) by equations (22~24) with the forward-backward algorithm; 4) We used the VB-M step to update the parameters by equations (27~29); 5) We calculated the lower bound, L q , by using equation (30) and judging its convergence, except for the first L q , by determining whether the difference from the previous L q was less than 0.001%; 6) If L q was not converged, we repeated the next iteration step by repeating steps 3) to 5); and 7) We optimized the state sequence by choosing a state with the highest probability at every frame. For the calculation in 4), we assigned u iπ = u A ij = 1, and different fixed values for a D , b D that gave maximum lower bounds for the observed trajectory data.
Heterologous expression and membrane preparation for in vitro biochemical assay
Heterologous expression of mGluR3 in HEK293 cells for in vitro biochemical assay was performed according to previously reported methods (20) . The plasmid DNA (10 μ g/100-mm dish) of mGluR3 or pCAG vector (mock) was transfected into HEK293 cells growing to ~40% confluency in DMEM/F12 supplemented with 10% FBS by the calcium-phosphate method. The cells were collected 48 h after transfection by centrifugation, and the pellet was washed with PBS (1 mL, pH 7.4). The cell pellet in a 1.5 mL tube was homogenized with a pellet mixer in 50% sucrose in buffer A (50 mM HEPES (pH 6.5) and 140 mM NaCl) prior to centrifugation. The supernatant containing the plasma membrane was diluted in two volumes of buffer A and recentrifuged. The membrane pellet was washed with buffer A and stored at -80 °C.
Western blotting
The mGluR3 containing membrane pellet was suspended in the sample buffer (62.5 mM Tris-HCl (pH 6.8), 4% SDS, 10% glycerol) with or without 2.5% βmercaptoethanol (ME). After 5.5% SDS-PAGE, the electrophoresed proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane and probed with the Rho1D4 antibody (primary antibody) and the HRP-linked anti-mouse IgG (secondary antibody, Cell Signaling #7076). Immunoreactive proteins were detected using the Amersham ECL prime Western blotting detection reagent (GE) with ImageQuant LAS 500 (GE).
To estimate the efficacy of RNAi of CLC, we transfected the siRNAs using the same protocol as described above for single-molecule imaging. After 2 days, the cells were harvested and homogenized using a pellet mixer. The cell lysate was boiled for 20 min in sample buffer containing 2.5% mercaptoethanol. After subjecting the lysate to 15% SDS-PAGE followed by transfer to a PVDF membrane, CLC and β-actin were probed using anti-CLC and anti-β-actin monoclonal antibodies, respectively. The HRPlinked secondary antibody reaction and detection of immunoreactive proteins were performed as described above.
[ 3 H]-Ligand-binding assay of mGluR3
The cell membranes containing mGluR3 were resuspended in HBSS (with 15 mM HEPES (pH 7.1), without NaHCO 3 (Sigma)), which are the same buffer conditions as for the single-molecule imaging. 
Saturation binding assay of TMR, SF650, and SiR
The HEK293 cells growing to ~90% confluence on a 100-mm dish were detached using the same protocol for passage, and suspended in DMEM/F12 (4 mL) was calculated as the difference between the total binding to cells expressing HaloTagfusion mGluR3 and the non-specific binding. The data were fitted with the Hill equation
where n is the Hill coefficient. 
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